tiprankstipranks
Trending News
More News >
Barinthus Biotherapeutics (BRNS)
NASDAQ:BRNS

Barinthus Biotherapeutics (BRNS) Revenue

Compare
90 Followers

Barinthus Biotherapeutics Revenue

Barinthus Biotherapeutics had a revenue of 0.00 in the quarter ending Mar 31, 2025, with 100.00%. This bring the company's revenue in the last twelve months to 5.80M, Decreased 0.00%. In the fiscal year ending Dec 31, 2024, Barinthus Biotherapeutics had annual revenue of 14.97M with 1766.46% growth.
Revenue (ttm)
5.80M
Revenue Growth
4413.19%
P/S Ratio
2.48
Revenue/Employee
$142,562
Employees
105
Market Cap
$37.16M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
14.97M14.17M+1,766.46%
Dec 31, 2023
802.00K-43.90M-98.21%
Dec 31, 2022
44.70M44.44M+16,580.22%
Dec 31, 2021
268.00K-4.55M-94.44%
Dec 31, 2020
4.82M-2.05M-29.86%
Dec 31, 2019
6.87M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis